.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Accenture
Daiichi Sankyo
Queensland Health
Mallinckrodt
Moodys
QuintilesIMS
Julphar
Argus Health
McKinsey

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088873

« Back to Dashboard
NDA 088873 describes ENLON, which is a drug marketed by Mylan Institutional and is included in three NDAs. It is available from one supplier. Additional details are available on the ENLON profile page.

The generic ingredient in ENLON is atropine sulfate; edrophonium chloride. There are twenty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the atropine sulfate; edrophonium chloride profile page.

Summary for 088873

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antimyasthenic Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 088873

Mechanism of ActionCholinesterase Inhibitors

Suppliers and Packaging for NDA: 088873

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ENLON
edrophonium chloride
INJECTABLE;INJECTION 088873 ANDA Mylan Institutional LLC 67457-190 67457-190-15 1 VIAL, GLASS in 1 CARTON (67457-190-15) > 15 mL in 1 VIAL, GLASS

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10MG/ML
Approval Date:Aug 6, 1985TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Fish and Richardson
Dow
Baxter
UBS
Medtronic
Chubb
Fuji
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot